Success stories featured in latest edition of Australasian Biotechnology journal


Australia’s captivating biotech sector has ‘come alive’ in the latest edition of Australasian Biotechnology, AusBiotech’s official journal, in anticipation of the upcoming AusBiotech 2022 and AusBioInvest 2022 conferences.

The global biotech industry presents significant opportunities for Australian companies to expand into new growth markets, and highlights of this edition of the journal offer insights into recognising the strides local and international companies have taken to provide public access to therapeutics treatments.

Providing a platform for education, the journal strengthens and grows industry knowledge of Australian capabilities and enablers through commentary from a diverse range of authors. This edition’s themes include Australian commercialisation successes, investment trends and ventures, and incubators and accelerators. 

Read compelling insights from sector leaders, including What’s next in Australian investment by Scott Power, Research Analyst, Morgans Financial Limited, Australian innovation with global impact, by Dr Jackie Fairley, CEO, Starpharma and The secret sauce of biotech investor relations, by Jon Pilcher, CEO and Managing Director, Neuren Pharmaceuticals.

The journal toasts the successes of the industry today, including the AusMedtech 2022 Early-Stage Investment Forum winners, which showcases the emerging medtech stars who are tackling issues in the Australian community. 

This edition also contains regular features, including the AusBiotech CEO Report, and AusBioStock – an exclusive report from James Fletcher, Evans & Partners. The journal welcomes new AusBiotech members and holds a list of AusBiotech corporate members.  

In-depth commentary on the Australian and global biotechnology sector will continue at AusBiotech 2022, from 26 - 28 October, and AusBioInvest 2022 on 27 October, live and in person in Perth. AusBiotech thanks the support of its Host State Partners, WA Government and Business Events Perth.

The next edition of Australasian Biotechnology will be released in April 2023 and will feature Australian and international medtech success stories. Contact if you are interested in contributing, or to find out about advertising opportunities. 

Australasian Biotechnology is published bi-annually in partnership with Executive Media. Download the Australasian Biotechnology journal today.